OBJECTIVES This report summarizes the 5-year clinical and haemodynamic data from three
prospective, European multicentre trials with the Perceval sutureless aortic valve …

BACKGROUND: The Perceval S bioprosthesis (Sorin Biomedica Cardio Srl, Sallugia, Italy)
is a self-expanding valve designed to preserve aortic sinuses and sinotubular junction. We …

AIM: This study was planned to evaluate the outcome of patients aged≥ 80 years
undergoing combined conventional aortic valve replacement (AVR) and coronary artery …

Background: Surgical aortic valve replacement using conventional biological valves (CBVs)
is the standard of care for treatment of old patients with aortic valve disease. Recently, rapid …

OBJECTIVES The aim of the Cavalier trial was to evaluate the safety and performance of the
Perceval sutureless aortic valve in patients undergoing aortic valve replacement (AVR). We …

OBJECTIVE: Prolonged aortic crossclamping can increase mortality and morbidity after
aortic valve replacement in elderly and high-risk patients. Sutureless implantation of the …

Background With improving technologies and an increasingly elderly populations, there
have been an increasing number of therapeutic options available for patients requiring …

BACKGROUND: Sutureless aortic valve prostheses have the potential of shortening surgical
time. However, whether shorter operative times may also result in improved patient …

OBJECTIVE: The aim of this propensity-matched, multicenter study was to compare early
clinical and echocardiographic outcomes of patients undergoing transapical aortic valve …

Background The impact of sutureless prosthesis on the clinical outcome in minimally
invasive aortic valve replacement is still unclear. We assessed mid-term outcomes of the …